Identification of plasma Complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach-Reference-Cited by-同舟云学术

Identification of plasma Complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach

Published:2014-01 Issue: Volume:96 Page:1-12
ISSN:1874-3919
Container-title:Journal of Proteomics
language:en
Short-container-title:Journal of Proteomics

Author:

Kim Patrick Y.,Tan Owen,Diakiw Sonya M.,Carter Daniel,Sekerye Eric O.,Wasinger Valerie C.,Liu Tao,Kavallaris Maria,Norris Murray D.,Haber Michelle,Chesler Lou,Dolnikov Alla,Trahair Toby N.,Cheung Nai-Kong,Marshall Glenn M.,Cheung Belamy B.

Funder

Australian Postgraduate Research Scholarship, University of NSW, Program Grants from the NHMRC Australia, Cancer Institute NSW, and Cancer Council NSW

Publisher

Elsevier BV

Subject

Biochemistry,Biophysics

Reference39 articles.

1. Neuroblastoma: biological insights into a clinical enigma;Brodeur;Nat Rev Cancer,2003

2. Detecting minimal residual disease in neuroblastoma: still a ways to go;Kagedal;Clin Chem,2009

3. Profiling of nuclear extract proteins from human neuroblastoma cell lines: the search for fingerprints;Escobar;J Pediatr Surg,2005

4. MYCN, neuroblastoma and focal adhesion kinase (FAK);Beierle;Front Biosci (Elite Ed),2011

5. Neuroblastoma: biology, prognosis, and treatment;Park;Hematol Oncol Clin North Am,2010

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical Models of Neuroblastoma—Current Status and Perspectives;Cancers;2023-06-23

2. Protein Biomarker Discovery Studies on Urinary sEV Fractions Separated with UF-SEC for the First Diagnosis and Detection of Recurrence in Bladder Cancer Patients;Biomolecules;2023-06-01

3. More Abundant Superoxide Dismutase2 Protein Levels in Blood May Act as a Prognostic Marker for High-Risk Neuroblastoma Patients;Journal of Basic and Clinical Health Sciences;2023-01-31

4. Identification of immunization-related new prognostic biomarkers for papillary renal cell carcinoma by integrated bioinformatics analysis;BMC Medical Genomics;2021-10-07

5. Complement System: Promoter or Suppressor of Cancer Progression?;Antibodies;2020-10-25